Stephen Tyring, MD, PhD, MBA, University of Texas Health Science Center, Houston, TX, United States; Craig Leonardi, MD, Saint Louis University, St. Louis, MO, United States; Kim Papp, MD, Probity Medical Research, Waterloo, ON, Canada; Angelika Jahreis, MD, PhD, Amgen, Inc., Thousand Oaks, CA, United StatesLe texte complet de cet article est disponible en PDF.
Dr. Tyring has performed research supported by Amgen, Inc. but has no Amgen stock or other financial interest in Amgen. Dr. Leonardi is on the Clinical Advisory Board and a member of the Speakers Bureau for Amgen, Inc.; he is also a principal investigator in clinical trials, but he owns no stock or financial interests in Amgen. Dr. Papp has no significant financial interest in Amgen or in any of its competitors.
Research funded by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research